Challenges and recommendations for the health-economic evaluation of primary prevention programmes for dementia

被引:14
作者
Handels, Ron [1 ,2 ]
Wimo, Anders [2 ,3 ]
机构
[1] Maastricht Univ, Sch Mental Hlth & Neurosci, Alzheimer Ctr Limburg, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[2] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Neurogeriatr, Stockholm, Sweden
[3] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Gavle, Sweden
基金
瑞典研究理事会; 芬兰科学院;
关键词
Costs; economic evaluation; prevention; dementia; cognitive disorder; multidomain lifestyle intervention; DISEASE-MODIFYING TREATMENT; ALZHEIMERS-DISEASE; RISK-FACTORS; COST-EFFECTIVENESS; COGNITIVE DECLINE; OLDER-ADULTS; IMPACT; CARE; UTILITY; INTERVENTIONS;
D O I
10.1080/13607863.2017.1390730
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: We aimed to review health-economic evaluations of (hypothetical) intervention programmes for the primary prevention of dementia, and highlight challenges and provide recommendations for future research to estimate its cost-effectiveness. Methods: We searched the databases PubMed, MODEM, CEA and NHS for publications on the cost-consequence, -effectiveness, -utility or -benefit analysis of (hypothetical) interventions to reduce the risk of developing dementia for persons without dementia, and described the study characteristics. Results: Three publications described the evaluation of a hypothetical risk reduction due to physical activity or a multidomain intervention programme. Two studies reported a reduction of care costs. One study yielded two scenarios of increased care costs and one scenario of reduced care costs. Only one study reported the impact in QALY terms, and found a QALY gain. Conclusion: A few studies have evaluated a hypothetical multidomain prevention intervention, and reported that primary dementia prevention is potentially cost-saving or cost-effective. Various challenges remain to evaluate the health-economic impact of prevention interventions, including extrapolation of short-term trial effects, care costs in the dementia-free and life years gained, and accurate representation of usual care. We recommend extensive sensitivity analyses to examine the impact of assumptions regarding these aspects on the outcomes of cost-effectiveness studies.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 35 条
[1]  
CEA, 2017, COST EFF AN REG
[2]   MODEM: A comprehensive approach to modelling outcome and costs impacts of interventions for dementia. Protocol paper [J].
Comas-Herrera, Adelina ;
Knapp, Martin ;
Wittenberg, Raphael ;
Banerjee, Sube ;
Bowling, Ann ;
Grundy, Emily ;
Jagger, Carol ;
Farina, Nicolas ;
Lombard, Daniel ;
Lorenz, Klara ;
McDaid, David .
BMC HEALTH SERVICES RESEARCH, 2017, 17
[3]  
CRD, 2017, CTR REV DISS DAT
[4]   Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia [J].
Davis, Jennifer C. ;
Bryan, Stirling ;
Marra, Carlo A. ;
Hsiung, Ging-Yuek R. ;
Liu-Ambrose, Teresa .
BRITISH JOURNAL OF SPORTS MEDICINE, 2015, 49 (20) :1343-U80
[5]   Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies [J].
Deckers, Kay ;
van Boxtel, Martin P. J. ;
Schiepers, Olga J. G. ;
de Vugt, Marjolein ;
Munoz Sanchez, Juan Luis ;
Anstey, Kaarin J. ;
Brayne, Carol ;
Dartigues, Jean-Francois ;
Engedal, Knut ;
Kivipelto, Miia ;
Ritchie, Karen ;
Starr, John M. ;
Yaffe, Kristine ;
Irving, Kate ;
Verhey, Frans R. J. ;
Kohler, Sebastian .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (03) :234-246
[6]   Association between Cognitive Decline in Older Adults and Use of Primary Care Physician Services in Pennsylvania [J].
Fowler, Nicole R. ;
Morrow, Lisa A. ;
Tu, Li-Chuan ;
Landsittel, Douglas P. ;
Snitz, Beth E. ;
Rodriquez, Eric G. ;
Saxton, Judith A. .
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2012, 3 (03) :201-209
[7]   Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease [J].
Gustavsson, Anders ;
Green, Colin ;
Jones, Roy W. ;
Foerstl, Hans ;
Simsek, Deniz ;
de Vulpillieres, Frederic de Reydet ;
Luthman, Stefanie ;
Adlard, Nicholas ;
Bhattacharyya, Subrata ;
Wimo, Anders .
ALZHEIMERS & DEMENTIA, 2017, 13 (03) :312-321
[8]   Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment [J].
Handels, Ron L. H. ;
Joore, Manuela A. ;
Tran-Duy, An ;
Wimo, Anders ;
Wolfs, Claire A. G. ;
Verhey, Frans R. J. ;
Severens, Johan L. .
ALZHEIMERS & DEMENTIA, 2015, 11 (08) :896-905
[9]   Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement [J].
Husereau, Don ;
Drummond, Michael ;
Petrou, Stavros ;
Carswell, Chris ;
Moher, David ;
Greenberg, Dan ;
Augustovski, Federico ;
Briggs, Andrew H. ;
Mauskopf, Josephine ;
Loder, Elizabeth .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (03) :367-372
[10]   Future directions in Alzheimer's disease from risk factors to prevention [J].
Imtiaz, Bushra ;
Tolppanen, Anna-Maija ;
Kivipelto, Miia ;
Soininen, Hilkka .
BIOCHEMICAL PHARMACOLOGY, 2014, 88 (04) :661-670